News details - ir.schrodinger.com
3 days ago · Schrödinger to receive $150 million upfront and eligible to receive up to approximately $2.3 billion in milestone payments plus royalties Expanded multi-year software agreement enables technology deployment at significant scale across Novartis’s global research organization Schrödinger to host third quarter 2024 financial results webcast today at 8:00 a.m. ET Schrödinger, Inc. (Nasdaq ...
Schrödinger Announces Multi-Target Collaboration and
2 days ago · As part of the multi-year, multi-target research collaboration and license agreement, Schrödinger and Novartis will combine their existing research efforts to identify and advance therapeutics ...
Schrödinger Announces Multi-Target Collaboration and Expanded …
2 days ago · NEW YORK, November 12, 2024--Schrödinger today announced a multi-target collaboration and expanded software licensing agreement with Novartis.
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration ...
2 days ago · Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details. Schrodinger, Inc. (NASDAQ:SDGR) shares are trading higher on Tuesday.The company ...
Novartis pays Schrödinger $150M to form drug discovery pact
2 days ago · By Nick Paul Taylor Nov 12, 2024 8:55am. Novartis Schrodinger drug discovery Discovery Software. Novartis is paying $150 million for a closer look at Schrödinger’s catalog of programs. The Big ...
Schrödinger Announces Multi-Target Collaboration and
3 days ago · Schrödinger, Inc. (Nasdaq: SDGR) today announced a research collaboration and license agreement with Novartis to advance multiple development candidates into Novartis’s portfolio for further ...
Schrödinger’s stock pops as it enters collaboration pact with Novartis …
2 days ago · Schrödinger’s stock pops as it enters collaboration pact with Novartis worth up to $2.5 billion ... Ciara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York ...
Company Announcements - Financial Times
2 days ago · Novartis will be responsible for clinical development, manufacturing and global commercialization. Under the terms of the agreement, Novartis will pay Schrödinger $150 million upfront, and Schrödinger will also be eligible to receive up to $892 million in research, development and regulatory milestone payments.
Schrödinger’s stock pops as it enters collaboration pact with Novartis …
Schrödinger’s stock has fallen 38% in the year to date, while the S&P 500 has gained 25.5%. Of the six analysts covering the stock on FactSet, five have a buy rating and one has a hold rating ...
Schrodinger Inc. (SDGR) Announces Multi-Target Collaboration …
2 days ago · Schrödinger, Inc. (Nasdaq: SDGR) today announced a research collaboration and license agreement with Novartis to advance multiple development candidates into Novartiss portfolio for ...
- Some results have been removed